Combating AMR with Antimicrobial Peptides

A unique RNAi therapeutic to induce endogenous Antimicrobial Peptide Secretion against AMR infection

This technology releases a cocktail of natural antimicrobial peptides that are safe for the tissue and recalcitrant to the evolution of resistance.

Technology:
  • Infection prevention
  • Alternative antimicrobials
  • Antimicrobial stewardship
  • Microbial diagnostics
  • Antimicrobial compound/strategy
  • Removal antibiotics/bacteria

Microorganisms:
  • Bacteria
  • Viruses
  • Fungi
  • Yeasts
  • Parasites

Application:
  • Human
  • Veterinary
  • AgriFood
  • Environmental
  • Other

Development stage:
  • Research
  • Development
  • Validation
  • Market entry
  • Marketed product

Organization:
  • Institute
  • Company
  • Academia
  • NGO
  • Government

Partnering:
  • License
  • Co-develop
  • Outsource
  • Joint Venture
  • Sell

Funding organisation:

    Infectious disease area:

      Geographic origin:


        We are initiating a new private venture, budding out of inStem (Academic Institute), looking for co-developers, and investors interested in the pre-clinical and phase-1 trials of our innovation.

        A new venture budding out of inStem – developing RNAi therapies to combat AMR infections and accelerate wound-healing.

        We are a team with translational research and commercialization experience in the domain of wound-healing, skin fibrosis, and allied diseases.


        What is going on with AMR?
        Stay tuned with remarkable global AMR news and developments!